{{Rsnum
|rsid=1547651
|Chromosome=6
|position=43762907
|Orientation=plus
|GMAF=0.1295
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 76.9 | 15.4 | 7.7
| HCB | 82.2 | 17.8 | 0.0
| JPT | 75.0 | 22.7 | 2.3
| YRI | 84.1 | 15.9 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 82.2 | 17.8 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1547651
|Name_s=
|Gene_s=VEGFA
|Feature=
|Evidence=PubMed ID:17319747
|Annotation=This variant in the promoter region of the VEGFA gene was associated with increased risk for bladder cancer in a large-scale evaluation study of SNPs in candidate genes for cancer in 1,086 cases and 1,033 controls in Spain.
|Drugs=
|Drug Classes=
|Diseases=Urinary Bladder Neoplasms
|Curation Level=Curated
|PharmGKB Accession ID=PA162355806
}}

{{PMID Auto
|PMID=21316969
|Title=Polymorphisms of the vascular endothelial growth factor A gene and susceptibility to sporadic brain arteriovenous malformation in a Chinese population
}}

{{PMID Auto
|PMID=19308252
|Title=Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation.
|OA=1
}}

{{PMID Auto
|PMID=21706043
|Title=Polymorphisms of VEGFA gene and susceptibility to hemorrhage risk of brain arteriovenous malformations in a Chinese population.
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1547651
|overall_frequency_n=8
|overall_frequency_d=128
|overall_frequency=0.0625
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}